These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5653045)

  • 21. [Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
    Oda T
    Naika; 1969 Oct; 24(4):713-24. PubMed ID: 5358678
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary aldosteronism in normokalemic patients with adrenal incidentalomas.
    Bernini G; Moretti A; Argenio G; Salvetti A
    Eur J Endocrinol; 2002 Apr; 146(4):523-9. PubMed ID: 11916621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renin-angiotensin-aldosterone system: effect of the hypertensive agents on plasma renin activity and clinical application, especially in screening of primary aldosteronism and other simialr diseases].
    Suzuki T
    Jpn Circ J; 1970 Mar; 34(3):187-97. PubMed ID: 5468432
    [No Abstract]   [Full Text] [Related]  

  • 25. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 26. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
    Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
    J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on curable hypertension: special reference to renovascular hypertension and primary aldosteronism.
    Oda T
    Jpn Circ J; 1969 Dec; 33(12):1621-6. PubMed ID: 5396206
    [No Abstract]   [Full Text] [Related]  

  • 28. [The importance of primary aldosteronism as cause of "essential" hypertension].
    Siegenthaler W; Baumann K; Kiepenheuer K; Schönbeck M; Rhomberg F; Gysling E; Weidmann P; Werning C
    Schweiz Med Wochenschr; 1969 Jun; 99(23):825-8. PubMed ID: 5784017
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma renin activity and aldosterone secretion rate in hypertension. The distinction between primary and secondary hyperaldosteronism.
    Nielsen I; Jacobsen J
    Acta Med Scand; 1970 May; 187(5):401-9. PubMed ID: 5526958
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 32. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary salt intake in hypertensive patients with normal and low plasma renin activity.
    Adlin EV; Biddle CM; Channick BJ
    Am J Med Sci; 1971 Feb; 261(2):67-71. PubMed ID: 5550136
    [No Abstract]   [Full Text] [Related]  

  • 35. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of primary aldosteronism.
    Lund JO; Nielsen MD; Giese J
    Acta Med Scand Suppl; 1981; 646():54-7. PubMed ID: 7018185
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks.
    Cohen SL; Jhetam D; Da Silva J; Milne FJ; van der Walt A
    S Afr Med J; 1982 Dec; 62(25):941-4. PubMed ID: 6755766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary aldosteronism associated with acute intermittent porphyria. Report of a case.
    Basiliere J; Newcomer AD
    N Engl J Med; 1971 Sep; 285(11):595-8. PubMed ID: 5563960
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
    Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
    Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.